Studying Inflammation in People With Asthma and High Blood Pressure
Compares inflammation markers in adults with asthma alone and asthma with hypertension.
Plain-language title generated from the registry record
Registry title: Asthma and Primary Arterial Hypertension: an Inflammatory Link?
Key facts
- Where
- Tradate, ItalySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with moderate or severe asthma, with or without primary high blood pressure, to compare inflammation and lung function.
- Age
- 18 to 85 years
- Sex
- All sexes can join.
- Disease stage
- Moderate or severe asthma by GINA guidelines, with or without primary arterial hypertension by ESC/ESH guidelines.
- Earlier treatment
- No asthma attack in the last month that needed a change in asthma medicine.
Main reasons for not taking part
- Current smoker, or ex-smoker with more than 10 pack-years
- BMI above 30 kg/m2
- Pregnancy
- COPD, sleep apnoea, bronchiectasis, ABPA or atopic dermatitis
- Autoimmune disease, HIV, hepatitis B or hepatitis C, cancer now or in the past 5 years
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT07903805, who can take part
Where in Italy
- IRCSS ICS Maugeri TradateTradate, ItalyContact: Dina Visca, ProfessorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Istituti Clinici Scientifici Maugeri SpA
- Trial code
- NCT07903805
- Record updated
- 30 October 2026
- Original description
A low-intervention, prospective, experimental study will be conducted with the overall aim of assessing the inflammatory, functional and clinical differences between patients with asthma and those with asthma and hypertension, in order to improve our understanding of asthma and its comorbiditiesRead full original descriptionShow less
Asthma and Primary Arterial Hypertension: an Inflammatory Link?
A low-intervention, prospective, experimental study will be conducted with the overall aim of assessing the inflammatory, functional and clinical differences between patients with asthma and those with asthma and hypertension, in order to improve our understanding of asthma and its comorbidities
Inclusion: Age ≥18 and ≤85 years; Diagnosis of moderate/severe asthma according to current Global Initiative for Asthma (GINA) guidelines; Diagnosis of moderate/severe asthma according to current GINA guidelines and primary arterial hypertension according to current European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines; Patients able to collaborate in the required procedures; Signed informed consent.
Exclusion: History of asthma exacerbation requiring changing of pharmacological treatment in the previous month; Diagnosis of concomitant Chronic Obstructive Pulmonary Disease (COPD); Obstructive Sleep Apnoea Syndrome (OSA); Clinically significant bronchiectasis; Allergic bronchopulmonary aspergillosis (ABPA); Atopic dermatitis; Diagnosis of concomitant Autoimmune Diseases; History of Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), or (Hepatitis C Virus)HCV ; Active significant infection; Malignancy, current or within the past 5 years. Suspected malignancy or undefined neoplasms; Cognitive impairment; History of clinically significant chronic heart diseases; Active smoking status or ex-smoker with Pack/Year major than 10; BMI major than 30 Kg/m2; Pregnancy.